Prema Gurumurthy

1.0k total citations
40 papers, 802 citations indexed

About

Prema Gurumurthy is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Prema Gurumurthy has authored 40 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in Prema Gurumurthy's work include Tuberculosis Research and Epidemiology (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Prema Gurumurthy is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Prema Gurumurthy collaborates with scholars based in India, Australia and United States. Prema Gurumurthy's co-authors include K.M. Cherian, Prem Venkatesan, A. K. Hemanth Kumar, Geetha Ramachandran, Chandrasekaran Padmapriyadarsini, L Sekar, Soumya Swaminathan, S. Rajasekaran, Jaideep Mahendra and Kotturathu Mammen Cherian and has published in prestigious journals such as Clinical Infectious Diseases, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Prema Gurumurthy

37 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prema Gurumurthy India 16 249 237 142 107 107 40 802
Satoshi Kishino Japan 16 232 0.9× 176 0.7× 108 0.8× 197 1.8× 127 1.2× 56 711
Jens Rengelshausen Germany 16 333 1.3× 201 0.8× 263 1.9× 145 1.4× 208 1.9× 33 1.1k
A Ramachandran India 20 242 1.0× 93 0.4× 54 0.4× 315 2.9× 81 0.8× 60 1.3k
Debra S. Israel United States 15 171 0.7× 114 0.5× 154 1.1× 35 0.3× 122 1.1× 20 583
P Manoj United States 16 79 0.3× 104 0.4× 85 0.6× 109 1.0× 53 0.5× 63 794
Sepideh Elyasi Iran 17 318 1.3× 153 0.6× 132 0.9× 226 2.1× 384 3.6× 82 1.3k
Peng Cao China 17 204 0.8× 213 0.9× 134 0.9× 301 2.8× 109 1.0× 31 1.1k
Marc G. Sturgill United States 12 131 0.5× 126 0.5× 149 1.0× 142 1.3× 86 0.8× 32 842
Fatemeh Tavakoli Iran 15 123 0.5× 165 0.7× 46 0.3× 131 1.2× 50 0.5× 75 736

Countries citing papers authored by Prema Gurumurthy

Since Specialization
Citations

This map shows the geographic impact of Prema Gurumurthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prema Gurumurthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prema Gurumurthy more than expected).

Fields of papers citing papers by Prema Gurumurthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prema Gurumurthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prema Gurumurthy. The network helps show where Prema Gurumurthy may publish in the future.

Co-authorship network of co-authors of Prema Gurumurthy

This figure shows the co-authorship network connecting the top 25 collaborators of Prema Gurumurthy. A scholar is included among the top collaborators of Prema Gurumurthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prema Gurumurthy. Prema Gurumurthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurumurthy, Prema, et al.. (2017). Emergence of SFRP5 as a pleiotropic adipocytokine and its association with Wnt signaling pathways. Minerva Endocrinology. 42(3). 280–289. 11 indexed citations
2.
Gurumurthy, Prema, et al.. (2013). Antioxidant and free radical scavenging activity of triphala determined by using different in vitro models. Journal of Medicinal Plants Research. 7(39). 2898–2905. 59 indexed citations
3.
Gurumurthy, Prema, et al.. (2013). ROLE OF SERUM APOLIPOPROTEIN LEVELS IN INDIAN CHILDREN AND ADOLESCENTS.. International Journal of Pharma and Bio Sciences.
4.
Gurumurthy, Prema, et al.. (2013). Antioxidant and free radical scavenging activity of curcumin determined by using different in vitro and ex vivo models. Journal of Medicinal Plants Research. 7(36). 2680–2690. 93 indexed citations
5.
Gurumurthy, Prema, et al.. (2013). Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome. Indian Journal of Clinical Biochemistry. 29(3). 367–371. 30 indexed citations
6.
Gurumurthy, Prema, et al.. (2012). Pregnancy associated plasma protein-A (PAPP-A) as an early marker for the diagnosis of acute coronary syndrome. Indian Heart Journal. 64(2). 141–145. 16 indexed citations
7.
Gurumurthy, Prema, et al.. (2010). Heart Fatty Acid Binding Protein (H-FABP) as a Diagnostic Biomarker in Patients with Acute Coronary Syndrome. Heart Lung and Circulation. 19(11). 660–664. 33 indexed citations
8.
Gurumurthy, Prema, et al.. (2010). Plasma Total Nitric Oxide and Endothelial Constitutive Nitric Oxide Synthase (ecNOS) Gene Polymorphism: A Study in a South Indian Population. Biochemical Genetics. 49(1-2). 96–103. 7 indexed citations
9.
Gurumurthy, Prema, et al.. (2010). Serum E‐selectin levels in Indian children and adolescents: Relation to clinical and biochemical parameters. Pediatrics International. 53(1). 40–45. 3 indexed citations
10.
Gurumurthy, Prema, et al.. (2009). Increased serum concentrations of Soluble CD40 Ligand as a prognostic marker in patients with Acute Coronary Syndrome. Indian Journal of Clinical Biochemistry. 24(3). 229–233. 7 indexed citations
11.
Gurumurthy, Prema, et al.. (2009). Lipid Profile and Non-enzymic Antioxidant Status in Patients with Acute Coronary Syndrome in South India. Heart Lung and Circulation. 19(2). 75–80. 2 indexed citations
12.
Gurumurthy, Prema, et al.. (2009). Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome. Heart Asia. 1(1). 41–46. 4 indexed citations
13.
Kumar, A. K. Hemanth & Prema Gurumurthy. (2004). Ofloxacin pharmacokinetics in saliva. Indian Journal of Pharmacology. 36(2). 80–83. 6 indexed citations
14.
Immanuel, Chandra, et al.. (2002). Dose related pharmacokinetics of ofloxacin in healthy volunteers.. PubMed. 6(11). 1017–22. 9 indexed citations
15.
Ramachandran, Geetha, et al.. (1999). Cytochrome P-450 in drug-resistant Mycobacterium tuberculosis. NOT FOUND REPOSITORY (Indian Institute of Science Bangalore).
16.
Gurumurthy, Prema, Geetha Ramachandran, A. K. Hemanth Kumar, et al.. (1998). Simple spectrofluorimetric and microbiological assay methods for the estimation of ofloxacin in biological fluids. Indian Journal of Pharmacology. 30(4). 263–266. 5 indexed citations
17.
Gurumurthy, Prema, et al.. (1998). Effect of Liv.100 against antitubercular drugs (isoniazid, rifampicin and pyrazinamide) induced hepatotoxicity in rats. Indian Journal of Pharmacology. 30(4). 233–238. 27 indexed citations
18.
Gurumurthy, Prema, et al.. (1990). Salivary levels of isoniazid and rifampicin in tuberculous patients. Tubercle. 71(1). 29–33. 20 indexed citations
19.
Gurumurthy, Prema, R Parthasarathy, G.R.K. Sarma, et al.. (1984). Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.. PubMed. 129(1). 58–61. 54 indexed citations
20.
Gurumurthy, Prema, et al.. (1984). Assay Of Ethambutol In Pharmaceutical Preparations. Lung India. 2(1). 143. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoshi Kishino Breakdown of academic impact, for papers by Jens Rengelshausen Breakdown of academic impact, for papers by A Ramachandran Breakdown of academic impact, for papers by Debra S. Israel Breakdown of academic impact, for papers by P Manoj Breakdown of academic impact, for papers by Sepideh Elyasi Breakdown of academic impact, for papers by Peng Cao Breakdown of academic impact, for papers by Marc G. Sturgill Breakdown of academic impact, for papers by Fatemeh Tavakoli
Rankless by CCL
2026